Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx) - GlobeNewswire

  1. Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx)  GlobeNewswire
  2. After leadership shuffle, Akcea hands heart drug to Pfizer for $250M  FierceBiotech
  3. Here's Why Akcea Therapeutics Jumped 30% Today  The Motley Fool
  4. Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B  Genetic Engineering & Biotechnology News
  5. What Happened in the Stock Market Today  Motley Fool
  6. View full coverage on Google News


from Top stories - Google News October 07, 2019 at 04:50PM

Comments

Popular posts from this blog

Jared Leto Was Responsible for the "We Live in a Society" Line in the 'Zack Snyder's Justice League' Trailer - /FILM

How to keep Amazon, Apple, and Google from listening to your Alexa, Siri, and Assistant recordings - TechHive

Exclusive: IAEA found uranium traces at Iran 'atomic warehouse' - diplomats - Reuters